ArticleAmerican journal of translational research2025
Analgesic and anti-inflammatory activities of mangiferin gel for musculoskeletal injuries in cancer patients.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMusculoskeletal injuries, a global public health concern, are among the most significant causes of long-lasting disability and meager performance in activities of daily living (ADLs).
methodsMangiferin (5%) was used to formulate a gel, extracted from aqueous-methanolic (30:70) extracts of M. indica leaf. Participants (n = 200) diagnosed with musculoskeletal injuries were separated into four groups (n = 50/group). Group I and II received phonophoresis with 5% mangiferin gel and 1% diclofenac gel, respectively, while Group III and IV received superficial massage with the same gels. Color, stability test, pH, spreadability test, pain, onset of pain relief, stiffness, ADLs were evaluated through the Numeric Pain Rating Scale (NPRS), Global Pain Relief Scale (GPRS), and Western Ontario and McMaster Universities Arthritis Index (WOMAC) Scale.
resultsNPRS was relieved in Group-I, while WOMAC was also reduced in Group-I, along with ADLs and stiffness measures; this improvement was greater than that in Group-II for all measures. Also, the NPRS of Group III was reduced along with WOMAC and ADLs scores and stiffness, more effectively that the same measures in Group IV.
conclusionMangiferin gel 5% has been proven more effective than diclofenac diethyl-ammonium gel 1% in treating human musculoskeletal injuries. Phonophoresis enhanced the effect of both gels, strongly suggesting that the topical application of mangiferin gel combined with phonophoresis could be a valuable therapeutic alternative to reduce inflammation and relieve pain significantly. The formulation of mangiferin gel is nature-based, cost-effective, eco-friendly, and prepared easily.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.